XOMAP

XOMA Corporation

Price

return (12m)

p/e

-9.98

p/bv

3.53

DIVIDEND YIELD

8.50%

XOMAP price

XOMA

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*The amount considers the reinvestment of dividends.

Return on Investment XOMAP

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals XOMAP

Valuation

P/E

-9.98

Sector -3.10

Industry -3.10

P/BV

3.53

Sector 1.78

Industry 1.78

P/Revenue (PSR)

13.84

Sector 2.00

Industry 2.00

EV/EBITDA

-17.46

Sector -202.91

Industry -202.91

EV/EBIT

-17.21

Sector -40.75

Industry -40.75

P/EBITDA

-19.70

Sector -19.52

Industry -19.52

P/EBIT

-19.41

Sector -64.80

Industry -64.80

P/Total Assets

1.34

Sector 1.06

Industry 1.06

P/Net Current Assets

Sector -9.29

Industry -9.29

P/Working Capital

Sector -121.95

Industry -121.95

EPS

-2.54

Sector -1.78

Industry -1.78

BVPS

7.20

Sector 2.01

Industry 2.01

Efficiency

Gross Margin

90.61%

Sector 41.24%

Industry 41.24%

EBITDA Margin

-22.78%

Sector -21,194.51%

Industry -21,194.51%

EBIT Margin

-71.26%

Sector -35.37%

Industry -35.37%

Net Profit Margins

-100.00%

Sector -35.81%

Industry -35.81%

Asset Turnover

0.03

Sector 0.03

Industry 0.03

Profitability

ROE

-35.33%

Sector -57.47%

Industry -57.47%

ROA

-13.41%

Sector -59.48%

Industry -59.48%

ROIC

Sector -1,878.27%

Industry -1,878.27%

Dividends

Dividend yield

8.50%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

Sector 2.92

Industry 2.92

Net Debt / EBITDA

2.24

Sector -19.80

Industry -19.80

Net Debt / EBIT

2.21

Sector -4.14

Industry -4.14

Net Debt / Equity

-0.40

Sector -33,113.00

Industry -33,113.00

Gross Debt / Equity

1.27

Sector -0.84

Industry -0.84

Equity/Assets

0.38

Sector 0.46

Industry 0.46

Liabilities/Assets

0.62

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals XOMAP

DRAG THE FRAME TO SEE MORE DATA

Assets	Price ($)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
XOMAP XOMA Corporation	$0.00	-100.00%	8.50%	-9.98	3.53	-35.33%	-100.00%
PFE Pfizer Inc.	$30.44	36.07%	5.73%	39.46	2.00	4.97%	6.80%
ABBV AbbVie Inc.	$295.11	35.26%	2.31%	53.66	0.00	-%	14.76%
NVO Novo Nordisk A/S	$39.80	-16.51%	4.76%	9.52	5.05	53.11%	35.32%
MRK Merck & Co. Inc.	$149.46	77.69%	2.34%	113.15	8.55	7.56%	4.77%
AZN AstraZeneca PLC	$187.27	15.68%	1.73%	22.38	5.77	27.27%	16.95%
ZTS Zoetis Inc.	$80.24	-43.19%	2.58%	12.83	10.75	83.77%	27.69%
AMGN Amgen Inc.	$469.71	66.32%	2.13%	28.86	21.58	91.47%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$912.86	40.12%	0.46%	19.24	2.63	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$130.85	100.51%	0.00%	35.61	102.60	288.13%	24.86%
MCK McKesson Corporation	$1,005.04	25.05%	0.34%	26.09	-31.01	-118.84%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$559.48	34.10%	0.00%	30.31	6.59	21.76%	35.00%
CAH Cardinal Health Inc.	$253.37	55.51%	0.81%	34.72	-21.85	-62.92%	0.67%
ARGX argenx SE	$905.64	10.18%	0.00%	13.26	-	-%	25.42%
HRMY Harmony Biosciences Holdings Inc.	$38.76	32.20%	0.00%	11.35	2.06	18.14%	18.88%
BIIB Biogen Inc.	$254.75	72.29%	0.00%	45.08	2.00	4.58%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

XOMAP - Historical Dividends

Current Dividend Yield

8.50%

5-year average Dividend Yield

9.94%

Current Payout

—

5-year average Payout

—

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	07/01/2026	07/15/2026	0.53910000
Dividends	04/01/2026	04/15/2026	0.53910000
Dividends	01/01/2026	01/15/2026	0.53910000
Dividends	10/02/2025	10/15/2025	0.53910000
Dividends	07/02/2025	07/15/2025	0.53910000
Dividends	04/02/2025	04/15/2025	0.53910000
Dividends	01/02/2025	01/15/2025	0.53910000
Dividends	10/02/2024	10/15/2024	0.53910000
Dividends	07/02/2024	07/15/2024	0.53910000
Dividends	04/01/2024	04/15/2024	0.53910000
Dividends	01/01/2024	01/16/2024	0.53910000
Dividends	10/03/2023	10/16/2023	0.53910000
Dividends	06/29/2023	07/17/2023	0.53910000
Dividends	03/31/2023	04/17/2023	0.53910000
Dividends	01/02/2023	01/17/2023	0.53910000
Dividends	09/29/2022	10/17/2022	0.53910000
Dividends	06/29/2022	07/15/2022	0.53910000
Dividends	03/30/2022	04/15/2022	0.53910000
Dividends	12/31/2021	01/18/2022	0.52340000
Dividends	09/29/2021	10/15/2021	0.53910000
Dividends	06/30/2021	07/15/2021	0.53910000
Dividends	03/31/2021	04/15/2021	0.71880000

ABOUT XOMA

XOMA Corporation

Average Investor10 user rating

4.0 (5 people)

United States

45 years

Founded: 1981

2020

Time since IPO - 6 years

14

Employees

XOMA Corporation (United States) is listed on the Nasdaq and has a market capitalization of $298.98 million, with shareholders equity totaling $84.81 million.

The company employs approximately 14 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, XOMA Corporation reported $21.61 million in revenue, generating net income of $-29.96 million.

Key financial metrics include a P/E ratio of -9.98, a price-to-book (P/B) ratio of 3.53, and a trailing twelve-month dividend yield of 8.50%.

The company trades under the ticker XOMAP.

Market cap

$298.98 million

Net worth

$84.81 million

$84,810,000.00

Assets

$223.34 million

$223,340,000.00

Total Shares Outstanding

11.78 million

11,780,000

Average Daily Trading Volume

$2.30 Thousand

$2,298.14

Sector

Health Care

Industry

Biotechnology

XOMAP

XOMAP revenue and profits

Financial Results XOMAP

DRAG THE FRAME TO SEE MORE DATA

XOMAP cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$1,005.04 24,48% (12M)

P/E

26.09

0.34%

ROE

-118.84%

P/BV

-31.01

CAH - Cardinal Health

$253.37 34,07% (12M)

P/E

34.72

0.81%

ROE

-62.92%

P/BV

-21.85

ABBV - AbbVie

$295.11 39,67% (12M)

P/E

53.66

2.31%

ROE

P/BV

0.00

MRK - Merck & Co.

$149.46 78,93% (12M)

P/E

113.15

2.34%

ROE

7.56%

P/BV

8.55

AZN - AstraZeneca

$187.27 16,56% (12M)

P/E

22.38

1.73%

ROE

27.27%

P/BV

5.77

PFE - Pfizer

$30.44 32,16% (12M)

P/E

39.46

5.73%

ROE

4.97%

P/BV

2.00

BMY - Bristol-Myers Squibb

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$1,005.04 24,48% (12 M)

P/L

26.09

0.34%

ROE

-118.84%

P/VP

-31.01

CAH - Cardinal Health

$253.37 34,07% (12 M)

P/L

34.72

0.81%

ROE

-62.92%

P/VP

-21.85

ABBV - AbbVie

$295.11 39,67% (12 M)

P/L

53.66

2.31%

ROE

P/VP

0.00

MRK - Merck & Co.

$149.46 78,93% (12 M)

P/L

113.15

2.34%

ROE

7.56%

P/VP

8.55

AZN - AstraZeneca

$187.27 16,56% (12 M)

P/L

22.38

1.73%

ROE

27.27%

P/VP

5.77

PFE - Pfizer

$30.44 32,16% (12 M)

P/L

39.46

5.73%

ROE

4.97%

P/VP

2.00

BMY - Bristol-Myers Squibb

Frequently Asked Questions

What is the price of XOMA (XOMAP) today?

The current price of XOMA (XOMAP) is $0.00. The stock began the year trading around $26.87 and is currently priced at $0.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does XOMA (XOMAP) pay dividends?

XOMA (XOMAP) distributed dividends in the last year, in the months of January, April and July totaling $1.62. The Dividend Yield for the last 12 months is 8.50%.

Is XOMA (XOMAP) a good investment?

XOMA (XOMAP) is currently trading at $0.00 with a P/E ratio of -9.98. This represents a -1,072% premium compared to its historical average P/E. Over the past year, the stock paid $1.62 in dividends, resulting in a dividend yield of 8.50%. The total shareholder return over the same period was 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy XOMA (XOMAP) stock?

You can buy XOMA (XOMAP) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol XOMAP and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of XOMA (XOMAP) yield today?

Over the past month, XOMA (XOMAP) has returned 0.00% — 0.00% over the past year, and 0.00% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 1.62 per share in dividends, resulting in a dividend yield of 8.50%.

If you were to purchase 100 shares of XOMA (XOMAP) today at the current price of $0.00 your total investment would be $0.00.

Based on historical performance, the investment would have grown to approximately:

$0.00 after 1 year
$0.00 after 5 years
$0.00 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

XOMAP

XOMA Corporation

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment XOMAP

Target price created!

Delete target price?

Your Target Price strategy deserves unlimited alerts

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING XOMAP WITH OTHER STOCKS

type

Ex - Dividend Date

payment date

value

ABOUT XOMA

XOMA Corporation

United States

45 years

2020

14

Financial Results XOMAP

XOMAP cash flow

Asset, Revenue and Profit Growth - XOMAP

XOMAP balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BMY - Bristol-Myers Squibb

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BMY - Bristol-Myers Squibb

Frequently Asked Questions